Showing results (41-50 of 63) with videos related to
Sort By:
Pageof 7
Forensic Science International|November 5, 2005
The relevance of the detection of troponins to the forensic diagnosis of cardiac contusionJan Peter, Andreas Kirchner, Eberhard Kuhlisch, et al.Clinical Toxicology (Philadelphia, Pa.)|July 9, 2008
Pediatric plant exposures in Germany, 1998-2004Jörg Pietsch, Ingrid Koch, Maren Hermanns-Clausen, et al.Analytica Chimica Acta|June 16, 2009
Headspace solid-phase microextraction-gas chromatography-mass spectrometry determination of the characteristic flavourings menthone, isomenthone, neomenthol and menthol in serum samples with and without enzymatic cleavage to validate post-offence alcohol drinking claimsKatja Schulz, Martin Bertau, Katja Schlenz, et al.Journal of Neurotrauma|June 26, 2013
S100B and NSE as useful postmortem biochemical markers of traumatic brain injury in autopsy casesBenjamin Ondruschka, Dirk Pohlers, Gerald Sommer, et al.Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 15, 2007
Combination of EGFR/HER2 tyrosine kinase inhibition by BIBW 2992 and BIBW 2669 with irradiation in FaDu human squamous cell carcinomaChristina Schütze, Annegret Dörfler, Wolfgang Eicheler, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 16, 2017
EGFR-amplification plus gene expression profiling predicts response to combined radiotherapy with EGFR-inhibition: A preclinical trial in 10 HNSCC-tumour-xenograft modelsLydia Koi, Steffen Löck, Annett Linge, et al.Journal of Chromatography. A|October 14, 2008
Headspace solid-phase microextraction-gas chromatography-mass spectrometry for the quantitative determination of the characteristic flavouring agent eugenol in serum samples after enzymatic cleavage to validate post-offence alcohol drinking claimsKatja Schulz, Katja Schlenz, Steffen Malt, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 27, 2010
CD133 expression is not selective for tumor-initiating or radioresistant cell populations in the CRC cell line HCT-116Claudia Dittfeld, Antje Dietrich, Susann Peickert, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 25, 2009
CD133 expression is not selective for tumor-initiating or radioresistant cell populations in the CRC cell lines HCT-116Claudia Dittfeld, Antje Dietrich, Susann Peickert, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 24, 2010
Radiobiological hypoxia, histological parameters of tumour microenvironment and local tumour control after fractionated irradiationAla Yaromina, Howard Thames, Xuanjing Zhou, et al.Pageof 7